Hagop M Kantarjian

303PUBLICATIONS
440CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (303)

|Aug 05, 2026
Treatment of adult acute lymphoblastic leukemia-a therapeutic revolution in the making.

|Jul 24, 2026
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

|Jul 22, 2026
Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Jul 16, 2026
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

|Jul 06, 2026
Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Pageof 51

Frequent Collaborators

170 joint publications

Elias Jabbour

141 joint publications

Tapan M Kadia

122 joint publications

Navel G Daver

118 joint publications

Courtney DiNardo